Darrin Mark Breaux, MD | |
8888 Summa Ave, Baton Rouge, LA 70809-3772 | |
(225) 769-0933 | |
(225) 769-6255 |
Full Name | Darrin Mark Breaux |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 29 Years |
Location | 8888 Summa Ave, Baton Rouge, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902807167 | NPI | - | NPPES |
1483281 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 022557 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Our Lady Of The Lake Regional Medical Center | Baton rouge, LA | Hospital |
Baton Rouge General Medical Center | Baton rouge, LA | Hospital |
St James Parish Hospital | Lutcher, LA | Hospital |
Surgical Specialty Center Of Baton Rouge | Baton rouge, LA | Hospital |
West Feliciana Parish Hospital | Saint francisville, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Baton Rouge Cardiology Center | 2163336942 | 29 |
Cardiovascular Specialty Care Center Of Baton Rouge Llc | 2769882992 | 13 |
News Archive
Now, in new research posted to the preprint server bioRxiv*, scientists use an experimental structure of the Spike RBD domain co-crystallized with part of the ACE2 receptor and several in silico methods to analyze the possible impacts of three amino acid replacements (Spike K417N, E484K, N501Y) concerning ACE2 binding.
"The Tennessee Senate on Thursday approved a bill to allow state hospitals to pay a fee to avoid $659 million in TennCare cuts. Democratic Gov. Phil Bredesen had originally proposed cutting $201 million from the state's expanded Medicaid program to help balance the states [sic] budget. Those cuts would be averted through the hospital assessment" (4/29).
Our new paper published in the Journal of Alzheimer's Disease provides evidence that cooking foods at high temperatures increases the risk of Alzheimer's disease. This study looked at the content of advanced glycation end products (AGEs) in national diets and clinical studies comparing and compared total AGEs to Alzheimer's disease rates.
The U.S. Food and Drug Administration (FDA) has approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease (vWD).
"More than 140 nations adopted the first legally binding international treaty on Saturday aimed at reducing mercury emissions, after four years of negotiations on ways to set limits on the use of a highly toxic metal," the Associated Press/New York Times reports.
› Verified 4 days ago
Entity Name | Baton Rouge Cardiology Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144377102 PECOS PAC ID: 2163336942 Enrollment ID: O20040413000233 |
News Archive
Now, in new research posted to the preprint server bioRxiv*, scientists use an experimental structure of the Spike RBD domain co-crystallized with part of the ACE2 receptor and several in silico methods to analyze the possible impacts of three amino acid replacements (Spike K417N, E484K, N501Y) concerning ACE2 binding.
"The Tennessee Senate on Thursday approved a bill to allow state hospitals to pay a fee to avoid $659 million in TennCare cuts. Democratic Gov. Phil Bredesen had originally proposed cutting $201 million from the state's expanded Medicaid program to help balance the states [sic] budget. Those cuts would be averted through the hospital assessment" (4/29).
Our new paper published in the Journal of Alzheimer's Disease provides evidence that cooking foods at high temperatures increases the risk of Alzheimer's disease. This study looked at the content of advanced glycation end products (AGEs) in national diets and clinical studies comparing and compared total AGEs to Alzheimer's disease rates.
The U.S. Food and Drug Administration (FDA) has approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease (vWD).
"More than 140 nations adopted the first legally binding international treaty on Saturday aimed at reducing mercury emissions, after four years of negotiations on ways to set limits on the use of a highly toxic metal," the Associated Press/New York Times reports.
› Verified 4 days ago
Entity Name | Cardiovascular Specialty Care Center Of Baton Rouge Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033486881 PECOS PAC ID: 2769882992 Enrollment ID: O20210609003446 |
News Archive
Now, in new research posted to the preprint server bioRxiv*, scientists use an experimental structure of the Spike RBD domain co-crystallized with part of the ACE2 receptor and several in silico methods to analyze the possible impacts of three amino acid replacements (Spike K417N, E484K, N501Y) concerning ACE2 binding.
"The Tennessee Senate on Thursday approved a bill to allow state hospitals to pay a fee to avoid $659 million in TennCare cuts. Democratic Gov. Phil Bredesen had originally proposed cutting $201 million from the state's expanded Medicaid program to help balance the states [sic] budget. Those cuts would be averted through the hospital assessment" (4/29).
Our new paper published in the Journal of Alzheimer's Disease provides evidence that cooking foods at high temperatures increases the risk of Alzheimer's disease. This study looked at the content of advanced glycation end products (AGEs) in national diets and clinical studies comparing and compared total AGEs to Alzheimer's disease rates.
The U.S. Food and Drug Administration (FDA) has approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease (vWD).
"More than 140 nations adopted the first legally binding international treaty on Saturday aimed at reducing mercury emissions, after four years of negotiations on ways to set limits on the use of a highly toxic metal," the Associated Press/New York Times reports.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Darrin Mark Breaux, MD 5231 Brittany Dr, Baton Rouge, LA 70808-9143 Ph: (225) 769-0933 | Darrin Mark Breaux, MD 8888 Summa Ave, Baton Rouge, LA 70809-3772 Ph: (225) 769-0933 |
News Archive
Now, in new research posted to the preprint server bioRxiv*, scientists use an experimental structure of the Spike RBD domain co-crystallized with part of the ACE2 receptor and several in silico methods to analyze the possible impacts of three amino acid replacements (Spike K417N, E484K, N501Y) concerning ACE2 binding.
"The Tennessee Senate on Thursday approved a bill to allow state hospitals to pay a fee to avoid $659 million in TennCare cuts. Democratic Gov. Phil Bredesen had originally proposed cutting $201 million from the state's expanded Medicaid program to help balance the states [sic] budget. Those cuts would be averted through the hospital assessment" (4/29).
Our new paper published in the Journal of Alzheimer's Disease provides evidence that cooking foods at high temperatures increases the risk of Alzheimer's disease. This study looked at the content of advanced glycation end products (AGEs) in national diets and clinical studies comparing and compared total AGEs to Alzheimer's disease rates.
The U.S. Food and Drug Administration (FDA) has approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease (vWD).
"More than 140 nations adopted the first legally binding international treaty on Saturday aimed at reducing mercury emissions, after four years of negotiations on ways to set limits on the use of a highly toxic metal," the Associated Press/New York Times reports.
› Verified 4 days ago
Dr. Jennifer L Rippon, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd Ste 409, Baton Rouge, LA 70808 Phone: 225-765-5864 Fax: 225-765-2013 | |
Gregory Fusilier, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 9103 Jefferson Hwy, Baton Rouge, LA 70809 Phone: 225-927-1190 Fax: 225-927-0988 | |
Dr. Yolanda Maria O'rourke, Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 7968 Essen Park, Baton Rouge, LA 70809 Phone: 225-761-6700 Fax: 225-761-6760 | |
Patricia D. Whatley, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Attn: Dee / Administration, Baton Rouge, LA 70808 Phone: 225-769-4044 | |
Frederick Cerise, Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3810 W Lakeshore Dr, Baton Rouge, LA 70808 Phone: 225-578-8886 | |
Dr. Jon Richard Jackson, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-4050 Fax: 225-765-4046 | |
Richard Frank Burroughs, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: Earl K. Long Hospital, Lsu Unit, 5825 Airline Highway, Baton Rouge, LA 70805 Phone: 225-358-3938 |